High Penetration Prodrugs for Specialized Environments

Publication ID: 24-11857545_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “High Penetration Prodrugs for Specialized Environments,” Published Technical Disclosure No. 24-11857545_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857545_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,545.

Summary of the Inventive Concept

Adapting high penetration prodrugs for use in high-security, disaster relief, and extreme weather conditions to improve treatment of pulmonary conditions in these unique operational environments.

Background and Problem Solved

The original patent disclosed high penetration prodrugs for treating pulmonary conditions, but these compositions may not be suitable for use in specialized environments where security, rapid absorption, and efficacy are paramount. The new inventive concept addresses these limitations by adapting the prodrugs and compositions for these unique operational environments.

Detailed Description of the Inventive Concept

The new inventive concept involves modifying the high penetration prodrugs and compositions to withstand extreme temperatures and humidity, ensure secure transportation and storage, and provide rapid absorption and efficacy in emergency situations. This is achieved through the use of specialized carriers, delivery mechanisms, and communication devices. For example, the pharmaceutical composition can be adapted for topical or oral administration in extreme weather conditions, and the delivery mechanism can be designed for secure administration in high-security environments.

Novelty and Inventive Step

The new claims introduce novel adaptations of the high penetration prodrugs and compositions for use in specialized environments, which are not obvious from the original patent. The inventive step lies in the specific modifications made to the prodrugs and compositions to address the unique challenges of these operational environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include adapting the prodrugs and compositions for use in other specialized environments, such as space exploration or military operations. Variations could include different types of carriers, delivery mechanisms, and communication devices tailored to specific operational environments.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of disaster relief, emergency response, and high-security environments. Target industries could include government agencies, emergency responders, and pharmaceutical companies specializing in niche markets.

Field of Art

Pharmaceutical compositions, specifically prodrug formulations for pulmonary condition treatment, with expertise in drug delivery mechanisms, carrier design, and pharmaceutical formulation adaptation

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical scientist or pharmacological engineer with advanced degree, experience in prodrug design, knowledge of drug delivery systems, and understanding of environmental adaptation strategies for pharmaceutical compositions

Obviousness Rationale

A skilled practitioner would recognize that adapting high penetration prodrugs for specialized environments represents a predictable extension of existing pharmaceutical design principles. The core prodrug technology from the source patent provides a foundational framework that can be systematically modified for different operational contexts. The variations disclosed in the PTD represent standard engineering approaches to expanding pharmaceutical utility through carrier and delivery mechanism modifications.

Obvious Combinations & Variations

Source Patent Element
Topical pharmaceutical formulation with specific structural compounds for pulmonary condition treatment
PTD Variation
Adapting the formulation for high-security and disaster relief environments with modified carrier systems
Obviousness Reasoning
A PHOSITA would recognize that carrier modification is a routine design choice for expanding pharmaceutical applicability, using known techniques of pharmaceutical engineering
Source Patent Element
Pharmaceutical compositions capable of penetrating biological barriers
PTD Variation
Developing delivery mechanisms specifically tailored for emergency and extreme environmental conditions
Obviousness Reasoning
Modifying drug delivery systems for specific environmental challenges represents a predictable solution using standard pharmaceutical design principles
Source Patent Element
Topical spray formulation for skin application
PTD Variation
Extending spray delivery to include communication devices for patient data transmission in emergency scenarios
Obviousness Reasoning
Integrating communication technology with pharmaceutical delivery is an obvious technological convergence for emergency medical applications
Source Patent Element
Pharmaceutical compositions for treating pulmonary conditions
PTD Variation
Screening drug candidates in simulated specialized environment conditions
Obviousness Reasoning
Expanding drug screening protocols to include environmental stress testing is a standard approach in pharmaceutical research and development
Source Patent Element
Prodrug compositions with specific structural modifications
PTD Variation
Adapting compositions to withstand extreme temperatures and humidity
Obviousness Reasoning
Environmental stability modifications represent a predictable engineering solution using known pharmaceutical stabilization techniques
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857545, the variations disclosed herein would be obvious to a person having ordinary skill in pharmaceutical formulation. The systematic adaptation of high penetration prodrug compositions for specialized environments represents a predictable technological extension that would be readily conceived by a skilled practitioner without requiring inventive insight beyond the existing pharmaceutical design paradigm.

Original Patent Information

Patent NumberUS 11,857,545
TitleHigh penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
Assignee(s)Techfields Pharma Co., Ltd.